Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
0.882
-0.039 (-4.22%)
Feb 21, 2025, 4:00 PM EST - Market closed
Biodesix Market Cap
Biodesix has a market cap or net worth of $128.30 million as of February 21, 2025. Its market cap has decreased by -29.80% in one year.
Market Cap
128.30M
Enterprise Value
159.40M
1-Year Change
-29.80%
Ranking
Category
Stock Price
$0.88
Market Cap Chart
Since the IPO on October 28, 2020, Biodesix's market cap has decreased from $472.57M to $128.30M, a decrease of -72.85%. That is a compound annual growth rate of -26.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 128.30M | -42.35% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | 535.07M | 13.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |